Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.50
Bid: 0.00
Ask: 135.00
Change: 0.00 (0.00%)
Spread: 32.50 (31.707%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 102.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Trading Update

2 May 2019 07:00

RNS Number : 8667X
McBride PLC
02 May 2019
 

2 May 2019

 

McBride plc

 

Directorate Change and Trading Update

 

Directorate Change

 

McBride plc (the "Company") announces that Rik De Vos, CEO, has informed the Board of his decision to leave the Company. A search will commence immediately and Rik has advised the Board that he will remain in position while his successor is being recruited.

 

John Coleman, Chairman, said:

"Rik has brought a strong vision and laid the foundations of the Company's transformation through the "Manufacturing our Future" strategy. I would like to take this opportunity to thank him on behalf of the Board and colleagues for his contribution. I would also like to thank Rik for agreeing to assist the Board to ensure a smooth handover of his responsibilities. The Board wishes him every success in his future endeavours."

 

Rik De Vos, CEO, said:

"In recent years, we have achieved much in a challenging trading environment. We have developed a clear strategy in "Manufacturing our Future" and delivered clear benefits from implementing the "Repair, Prepare, Grow" phases. However, I now consider that the Group requires different leadership to deliver the next phase of its growth ambitions. I'm confident that I will be leaving McBride well positioned to realise these ambitions."

 

An announcement will be made regarding Rik's successor and his departure date in due course.

 

Trading update

 

Following a weak third quarter trading period, the Group now anticipates that its full year earnings will be modestly lower than current market expectations, primarily as a result of weaker than expected sales activity in Germany, France and Italy.

 

The Group expects to provide a trading update for the 12 months ending 30 June 2019 in early July.

 

 

For further information please contact:

McBride plc

John Coleman, Chairman

Chris Smith, CFO

0161 203 7570

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

 Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

 

Addendum - CEO Remuneration disclosures

 

Salary and Benefits 

 

Rik will receive payments during his notice period of six months in accordance with his contractual entitlement namely base salary, payments in lieu of pension contributions and benefits. His benefits consist of a company car, private healthcare, disability insurance and life cover. Full details of Rik's contractual entitlements are included in the Remuneration report 2018.

 

Incentives

 

Entitlements to any bonus payment for the current financial year, unvested LTIP entitlements and unvested shares under the deferred bonus plan lapse with this resignation. Full details of unvested awards are included in the Remuneration report 2018.

 

Full details of any relevant payments will be included in the Directors' Remuneration Report for the relevant year. All payments to be made in the notice period are in accordance with the Directors' Remuneration Policy which was approved by shareholders on 24 October 2017.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGUUCAUPBUAP
Date   Source Headline
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.